Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergei V Popov

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Optics Express|July 12, 2013
Widely tunable polarization maintaining photonic crystal fiber based parametric wavelength conversionRobert T Murray, Edmund J R Kelleher, Sergei V Popov, et al.
Optics Letters|October 4, 2011
Picosecond bismuth-doped fiber MOPFA for frequency conversionBen H Chapman, Edmund J R Kelleher, Sergei V Popov, et al.
Journal of Hypertension|December 23, 2016
Denervation of the distal renal arterial branches vs. conventional main renal artery treatment: a randomized controlled trial for treatment of resistant hypertensionStanislav E Pekarskiy, Andrei E Baev, Victor F Mordovin, et al.
Bone|September 13, 2025
Integrating single-cell and bulk transcriptome analysis of fibroblast growth factor 23 (FGF23)-producing mesenchymal tumors reveals molecular basis of its secretory phenotypeSofia A Gronskaia, Ruslan M Deviatiiarov, Vladimir P Chekhonin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Optics Express|July 12, 2013
Widely tunable polarization maintaining photonic crystal fiber based parametric wavelength conversionRobert T Murray, Edmund J R Kelleher, Sergei V Popov, et al.
Optics Letters|October 4, 2011
Picosecond bismuth-doped fiber MOPFA for frequency conversionBen H Chapman, Edmund J R Kelleher, Sergei V Popov, et al.
Journal of Hypertension|December 23, 2016
Denervation of the distal renal arterial branches vs. conventional main renal artery treatment: a randomized controlled trial for treatment of resistant hypertensionStanislav E Pekarskiy, Andrei E Baev, Victor F Mordovin, et al.
Bone|September 13, 2025
Integrating single-cell and bulk transcriptome analysis of fibroblast growth factor 23 (FGF23)-producing mesenchymal tumors reveals molecular basis of its secretory phenotypeSofia A Gronskaia, Ruslan M Deviatiiarov, Vladimir P Chekhonin, et al.
Pageof 1